A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Revolution Medicines, Inc.
Carisma Therapeutics Inc
Advaxis, Inc.
Pfizer
H. Lee Moffitt Cancer Center and Research Institute
Seagen Inc.
Fate Therapeutics
H. Lee Moffitt Cancer Center and Research Institute
Amgen
Revolution Medicines, Inc.
MacroGenics
Ottawa Hospital Research Institute
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
University of Arkansas
Pharmacyclics LLC.